Carregant...
Pembrolizumab‐related pancreatitis with elevation of pancreatic tumour markers
Lung cancer immunotherapy is an effective treatment option; however, it can be hampered by adverse events, including pancreatitis, associated with excessive immune activation. Here, we report the case of a 70‐year‐old patient who presented with recurrent lung squamous carcinoma and was started with...
Guardat en:
| Publicat a: | Respirol Case Rep |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7000995/ https://ncbi.nlm.nih.gov/pubmed/32042430 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.525 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|